The present invention relates to a synergistic hepatoprotective pharmaceutical
composition comprising an effective amount of trans-tetracos-15-enoic acid (TCA)
and Apocynin (APO), the present invention also relates to a method of treatment
for hepatotoxicity in mammals and humans.